Drug Shortage Report for TOBRAMYCIN INJECTION, USP

Last updated on 2022-01-12 History
Report ID 6979
Drug Identification Number 02382814
Brand name TOBRAMYCIN INJECTION, USP
Common or Proper name TOBRAMYCIN INJECTION, USP
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) TOBRAMYCIN
Strength(s) 40MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 2ML 10VL
ATC code J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-05-01
Estimated end date Unknown
Actual end date 2022-01-06
Shortage status Resolved
Updated date 2022-01-12
Company comments Discontinued in shortage ID 152485. Last lot 7007753 Expiry October-31-2016.
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2022-01-12 French Compare
v13 2022-01-12 English Compare
v12 2022-01-12 French Compare
v11 2022-01-12 English Compare
v10 2017-08-28 French Compare
v9 2017-08-28 English Compare
v8 2017-08-24 French Compare
v7 2017-08-24 English Compare
v6 2017-07-21 French Compare
v5 2017-07-21 English Compare
v4 2017-05-05 French Compare
v3 2017-05-05 English Compare
v2 2017-04-13 French Compare
v1 2017-04-13 English Compare

Showing 1 to 14 of 14